UPDATE : Wednesday, January 23, 2019
Kanzen, Corea Therapeutics to co-develop next-generation anticancer immune cell therapy by Lee Han-soo 2019-01-23 21:29
Philips Korea to increase market share for CPAP with connected care strategy by Lee Han-soo 2019-01-23 16:21
Lilly returns rights for Hanmi’s BTK inhibitor candidate by Lee Han-soo 2019-01-23 10:21
Bridge Biotherapeutics licenses in new immunotherapy candidate by Lee Han-soo 2019-01-23 10:20
Court suspends FSC’s disciplinary ruling against Samsung BioLogics by Lee Han-soo 2019-01-22 22:30
Chong Kun Dang to co-promote CJ Healthcare’s gastroesophageal reflux treatment by Lee Han-soo 2019-01-22 16:03
‘We Want Healthcare’ introduces Lunit AI to its screening system by Lee Han-soo 2019-01-22 14:56
‘Appendicitis patients' prognosis remains similar if surgery is done within 24 hours’ by Lee Han-soo 2019-01-22 14:55
BMS, Ono Pharma wins more indication for Opdivo in EU by Lee Han-soo 2019-01-21 18:01
JW wins sales go-ahead for hemophilia A treatment by Lee Han-soo 2019-01-21 15:35
Novo Nordisk increases market share for mixed insulin in Korea by Lee Han-soo 2019-01-21 14:44
Sillajen releases interim results for combination cancer treatment in US by Lee Han-soo 2019-01-21 14:20
FDA OKs Samsung Bioepis’ first oncology medicine by Lee Han-soo 2019-01-21 11:43
Top Court’s ruling affects local companies’ base-altering strategies to avoid patents by Lee Han-soo 2019-01-18 16:36
OliX unveils new drug candidate for treating geographic atrophy by Lee Han-soo 2019-01-18 15:17
Celltrion wins patent dispute on Truxima by Lee Han-soo 2019-01-18 11:47
Over 1,000 bio-ventures set up in past 3 years by Lee Han-soo 2019-01-17 22:05
Daewoong to use cloud service for safe drug management by Lee Han-soo 2019-01-17 15:37
AMC develops tech to make infinite medical AI learning data by Lee Han-soo 2019-01-17 14:36
EN Cell to make Hanmi’s anti-cancer gene stem cell therapy by Lee Han-soo 2019-01-17 12:34
Back to Top